# Dual Antiplatelet Therapy (DAPT) in Patients With Baseline Thrombocytopenia

> **NCT06223607** · — · UNKNOWN · sponsor: **Methodist Health System** · enrollment: 300 (estimated)

## Conditions studied

- Baseline Thrombocytopenia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06223607
- **Lead sponsor:** Methodist Health System
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-08-22
- **Primary completion:** 2024-08-22
- **Final completion:** 2024-08-22
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2024-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06223607

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06223607, "Dual Antiplatelet Therapy (DAPT) in Patients With Baseline Thrombocytopenia". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT06223607. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*